SESN1 and osteosarcoma: Treatment of osteosarcoma cells with CX-5461, a G4 ligand, lead to induction of autophagic cell death caused by MTOR inhibition, activation of AMPK pathway and increased levels of p53, SESN1, SESN2 and CDKN1A53.